Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Blazedhorseman, this is from your post #558 on SUF board:
"We just needed a stop to the bleeding to give people an idea of where the bottom or begginning of a new range will begin.
I dont want to get ahead of myself but this could be the opportunnity of a lifetime right before our eyes and only time will tell. "
"We have been up, we have been down but we are not out. That is most important.
Blazed
Blazedhorse"
OI KAK STRASHNO!!!
Clancy, here is from my last e-mail to JB:
"PLEASE GIVE US GOOD NEWS!
And don't promise any more if you can't deliver in time."
Good luck to you.
4Godnmv, thank you for all updates!!!
My Dear Medifyers,
I will try to answer all of you in reference to Jonathan's e-mails.
I do appreciate getting them from him, otherwise we all simply don't have enough information from just a few not quite accurate PRs issued by the company.
I don't know why he chose to answer my e-mails ( but not all of them just a few select ones), but I hope it's because with all my criticism, and believe me I send enough of it, I always underline my very best wishes for JB, for the company and for us all.
He does not answer all of my emails, but I view his replies from the perspective of all of my answered and unanswered e-mails. Some people became very and unjustifiably critical to me for sending my e-mails to JB and to him for responding to them. This is why I decided to post just what I decided to post still having both our's and company's interests in mind. I promise to you my honesty and integrity, and it is up to you to believe or not to believe me.
ALWAYS DO YOUR OWN DD AND DO NOT RELAY ONLY ON INFORMATION POSTED ON THIS BOARD!!!
With my respect to all of you,
Solidgold
It was a great day, but still the beginning.
I'm not one of these five, but I roar for my shares and for RUSHNET. VERY GOOD NEWS today!!!
O/T: In my post 10646 I was positive on RSHN and I'm still very much so. Today's late news are VERY encouraging. Very good buy for the short and long holdings (my average is still higher).IMHO
Also feel much better today after exchanging e-mails with JB. We did quite an exchange and he was responding right away.
GO JOHNY GO!!!
Thanks Doc, even I'm in green in PYPR today. Don't have as many shares as you so.LOL
GOOD LUCK!!!
I'm not sure any more if I should post it or not.
Some of you are twisting my words now.
But here is some of what I just got from JB.
It is up to you to think about this anything you want, but I post it for some people who trust me.
This board is getting very agly.
But here is from JB:
"The German site going live is the start of the next phase for Medify. I DO NOT want any more mistakes because I am trying to help and support the company and its shareholders. I try to share my enthusiasm which is taken out of context and then used against me. But the end game has begun and will be demonstrated by our partners shortly.
Maybe www.medifysolutions.de will put a smile on your face?"
Good luck to all!
Trinity, I would like to be optimistic, but what does it have to do with Medify? Please don't give me any more b.s. from J.B., I got enough of it from his e-mails to me.
Yes, and every week has Monday/Friday. A delay for what?
The main factor for me is that where is no verification by the 3rd party of anything positive and Medify. At this point I have no value for any of Jonathan's predictions.
Border control
26 Oct 2006
Neil Versel
There are some who think that cross-European interoperability will promote high-quality, efficient care between institutions and across national frontiers. But other evidence and opinions suggest that it is only one step along a challenging path.
Nevertheless, the topic is gaining more and more attention - an interoperability showcase from the international Integrating the Healthcare Enterprise (IHE) project was a centrepiece of this month's World of Health IT conference and exhibition in Geneva.
“I think the idea of having interoperability across borders in Europe is a noble one, but it’s light years away,” says Murray Bywater, managing director of Hampshire-based Silicon Bridge Research. “A lot of the perceived wisdoms in this area are just plain wrong. They’re just fantasy.”
“It’s a seriously, seriously difficult challenge. It’s not just a technical challenge, it’s an operational challenge.”
Standardisation in any large industry is a long process, perhaps 10 years or more, and healthcare tends to move more slowly than most. “The question is: What do you use in the meantime?” Bywater says.
There is an adage in the US: 'Don’t let perfection be the enemy of progress.' The phrase, often attributed to internationally known patient safety advocate Dr Donald Berwick and frequently invoked by former US national health IT co-ordinator Dr David Brailer, certainly can apply to many European health systems.
A more pragmatic approach than aiming for a comprehensive, pan-European health record would be to narrow the focus to specific health communities, such as a local population or a group of patients with diabetes, Bywater suggests.
Bywater says that international record-sharing might be feasible in the context of a bipartite agreement between countries, such as the one that provides care for British citizens who spend their winters in Spain. “We don’t have the availability of treatment across borders yet,” he says, “Interoperability is meaningless if there is no provision for care.”
And then there are the issues of confidentiality and security. “If I were living six months out of the year in Spain, I wouldn’t necessarily want to have my health records online,” Bywater says. “But I would want to have my medication list online.” It also would be helpful for a foreign doctor to have information on chronic diseases or allergies, he adds.
Care before records
In some areas, access to care is a greater issue than interoperability or even basic information technology, says Joan Dzenowagis, a project manager with the World Health Organisation. While Dzenowagis witnessed this phenomenon first-hand while touring India, she says that it could equally apply to some of the less-developed Central European members of the EU.
“Given the choice between ICT and access, people are going to choose access every time,” Dzenowagis says.
Even in a single, large system like Kaiser Permanente in the US, interoperability is proving elusive. Kaiser is trying to build a common electronic health record for its 8 million patients and 12,000 physicians scattered across nine operational regions.
At the Geneva conference, EHR programme director Bruce Turkstra reported that the largest population Kaiser can exchange full medical information for is about 1.5 million to 2 million people. The rest just get health summaries, many of which are derived from payment claims rather than actual clinical data.
Fragmentation is prevalent even in Denmark, which has a total population of just 5.3 million, says Henrik Bjerregaard Jensen, chief executive of MedCom, the Danish national healthcare data network. But MedCom is overcoming barriers by cutting off bite-sized pieces.
Discharge and referral letters can be automated by interoperable messaging systems, Jensen says, and MedCom has done just that by specifying a single electronic form for each type of letter.
Since 1999, about 4,000 health institutions across Denmark with at least 100 different IT systems have built electronic messaging links are linked electronically, he says. Today, 81 per cent of e-prescriptions, 84 per cent of discharge orders and 97 per cent of lab reports traverse the MedCom network in standard format.
“Start with the basic needs,” Jensen advises.
Identification management is just emerging on the national level in most of Western Europe, says Dr Ramin Tavakolian of the Berlin-based Central Research Institute of Ambulatory Health Care in Germany, so full-fledged international projects simply are unrealistic in the near term.
Language
Ilias Iakovidis, deputy head of e-health in the EC’s Directorate General for Information Society and Media, says that mobility of the population across the EU is the “biggest nightmare” to those planning international interoperability of health information. Language and semantic barriers are among the myriad hurdles.
“The best way to address these problems is using a concept-based lexicon engine built upon a common pool of standardized, codified medical concepts,” says Theo Bosma, vice president of global sales for US-based Health Language Inc., who was in Geneva to present a session on clinical terminology.
The EC essentially is requiring every member state and some membership candidates to develop national plans for interoperability, through a Turkish-led programme called A Roadmap for Interoperability of eHealth Systems (RIDE). Iakovidis likens it to an international translation box since the participants have determined that is unrealistic to have one clinical data model for all of Europe.
Work on integration is happening at a governmental level within Europe. The EC’s e-health office is about half-way through a two-year project to determine how healthcare providers can issue a basic patient summary for use across borders.
Furthermore, the European Health Telematics Association (EHTEL) is attacking a single component — namely e-prescribing — as part of its Interoperability of Identification Management in eHealth (i2 Health) project. Based on a workshop on this topic in Amsterdam last March, i2 Health recommended “running demonstrators to achieve and prove cross-border interoperability,” following accepted European regulatory processes.
Both projects represent small but important steps along the road to international transition.
No, it's full of pure Medifola.
They look like us for the last 1.5 years...
Gamood, I hope that RSHN is very busy with orders by now. Do they produce enough to fill them?
THE LETTER is coming, THE LETTER is coming!!!
Did we invest in any other of these "good opportunities"?
The reason why Trevor and that other guy left the promising company could be the answer for all questions.
Was laughing, thanks you made my day.
And judges...
Trying to found logic in Medify's doing or saying is a waist of time. But it's what we are doing anyway.
ThatHawaiiGuy, I'm going to Waikiki next month. Anywhere I could get any RUSH product? Thank you.
Doc, so far I'm very impressed by how company is moving in the right direction. Also by how CEO is conducting his business and PRs.
If I would know the answers to your questions, I would gladly provide them to you. SSTY is making big promises (including getting out of grey), and huge announcements, but looks like PPS reflects the present status of all. Need real revenues to be shown to move up.
Yes Lem, and unfortunately I'm one of them.
On a positive side it's my pleasure to meet such a great group of nice people on this board. We may have our differences, but we all deserve a much happier continuation of our relationship.
I picture all of you and myself drinking expensive champagne together with JB and tosting him as our savior.
GO JOHNY GO!!! Despite of my criticism I STILL BELIEVE!!!
YOU CAN DO IT!!! YOU HAVE TO!!!
No, we are still in grey. For how much longer?
Hi Doc, are you going to change your name to verylongonpypr? LOL
BEST OF LUCK!
Thank you for proving my point.
Finally!!!
KG and others, again I want to make something very clear:
1. I'm not threatening anyone or anything.
2. I'm not happy that I was used to deliver false promises on behalf of the company to other shareholders.
3. I completely understand that JB is trying to do a very difficult task, but it doesn't take away his responsibility toward investors who trusted him and CO with thier hard making money.
4. Honesty and full discloser is a must in any business dealing, specifically when we relay on information given to us by the trusted party w/o conformation from else where.
5. Before sending last letter to JB I've send to him 2 small e-mails
on 10/20 :Jonathan,
any news today?
Regards.
on 10/23 :Hi Jonathan,
nothing started on last Friday.
Any good news today?
Regards,
based on his prior e-mail to me and got no responce on them.
6.I wish JB and Medify all the best I can, but their best MUST INCLUDE US AS SHAREHOLDERS.
7.I don't like even to entertain a thought of anyone trying to screw me in my a.s, even with the usage of vaselin, and I'm not going to sit and wait for this to come.
JONATHAN, I'M STILL BEHIND YOU, BUT YOU MUST TO SHOW THAT YOU ARE WITH US, SHAREHOLDERS.
I'm keeping the faith too, but preacher has to deliver.
MDFYforlong, you didn't get my meassage right. No threats were given to JB or Medify. It was just my opinion and an advise to JB to deliver as talked. He most certainly talked the talk and used my honest posting of his e-mails to the board. He most definitely missed or misled on the most promises given in his e-mails. I'm still one of his most loyal supporters, but accountability becomes a factor and a very big material factor at this point. Still hope for much better times for Jonathan, Medify and shareholders.
Just send e-mail to Jonathan:
Hi Jonathan,
from your last e-mail to me:
"It will begin this week! By the end of next week I will expect an extremely long letter praising the company ,the achievements and the success.
End of communications and the beginning of the future."
Nothing began last week, no PR today, and when you read IHUB you can clear see that THE LETTER will be coming to you and your company from the legal offices on behalf of shareholders.
Regardless of good news, bad news or no news coming your absolute inability to deliver anything as promised to your shareholders speaks very loud for whom you are.
This is definitely not the end of communications between you and shareholders.
You better walk the walk and do it now.
Doc, only 34 mil? Don't be so cheap. LOL
Lets all concentrate on the best hope for us with positive attitude. Good news this week will be our reward!
GO JOHNY GO!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
"Medify has an exclusive contract with Egton Medical Information Systems (EMIS), the U.K.'s leading IT supplier in primary healthcare, to provide its technology to EMIS users."
"Exlusive", but not according to EMIS. Very strange...
I'm for one still believe in miracles. The life is very unpredictable itself, and my lesson from it is sometime you just have to stick with it and try again and hope again.
I still belive in Medify and hope that Jonathan will come through for us all. Good luck next week!
Still didn't get a single share in any of the gold companies.
Did any of you get any of these? Thanks.